Fig. 2From: Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomographyRepresentative OCT imaging. Changes in fibrous cap thickness (white arrows) between baseline and follow-up in a patient with alirocumabBack to article page